Use of chemically modified heparin derivates in sickle cell disease

• 收藏
• 分享

专利权人:

DILAFORETTE AB

发明人:

Hans-Peter Ekre,Anna Leitgeb,Mats Wahlgren,Dagmar Pikas

申请号：

US14366603

公开号：

US09480702B2

申请日:

2012.12.19

申请国别(地区):

US

年份:

2016

代理人:

摘要：

The present invention relates to chemically modified heparin for use in the treatment of sickle cell disease, with an antifactor II activity of less than 10 IU/mg, an antifactor Xa activity of less than 10 IU/mg and an average molecular weight (Mw) between about 6.5 and 9.5 kDa.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/